Angiodynamics (ANGO) Raw Materials (2012 - 2014)

Angiodynamics' Raw Materials history runs 3 years deep, the most recent figure standing at $23.3 million for Q1 2014.

• Quarterly Raw Materials changed N/A year-over-year to $23.3 million in Q1 2014, while the trailing twelve-month figure through Feb 2014 was $23.3 million (changed N/A YoY) and the FY2013 annual result came in at $18.4 million, down 3.28% from the prior year.
• Raw Materials was $23.3 million for Q1 2014 at Angiodynamics, down from $24.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $24.3 million in Q4 2013 and bottomed at $18.4 million in Q2 2013.
• A 3-year average of $21.2 million and a median of $21.0 million in 2012 frame the typical range for Raw Materials.
• Peak annual rise in Raw Materials reached 7.67% in 2013, while the deepest fall reached 3.28% in 2013.
• Angiodynamics' Raw Materials stood at $20.2 million in 2012, then grew by 20.17% to $24.3 million in 2013, then retreated by 3.99% to $23.3 million in 2014.
• Business Quant data shows ANGO's Raw Materials at $23.3 million in Q1 2014, $24.3 million in Q4 2013, and $21.8 million in Q3 2013.